4//SEC Filing
Kane William P Jr 4
Accession 0000899243-23-004228
CIK 0001771917other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 6:16 PM ET
Size
7.3 KB
Accession
0000899243-23-004228
Insider Transaction Report
Form 4
Kane William P Jr
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-02-06+17,656→ 17,656 total - Award
Stock Option (Right to Buy)
2023-02-06+29,937→ 29,937 totalExercise: $192.15Exp: 2033-02-05→ Common Stock (29,937 underlying)
Footnotes (2)
- [F1]Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest annually in four 25% installments commencing on February 6, 2024, subject to continued service through such dates.
- [F2]25% of this option shall vest on February 6, 2024, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
Related Parties
1- filerCIK 0001813937
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 6:16 PM ET
- Size
- 7.3 KB